IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q4 2019 Holdings

Filed 2020-02-12 | 15 holdings | $38.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$22.1M515,78856.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$12.5M78,13832.3%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$4.1M29,67610.6%
Zogenix IncCOM NEW98978L204$24.3K466,8750.1%
Insmed Inc(INSM)COM PAR $.01457669307$23.6K988,9990.1%
Amarin Corp PLCSPONS ADR NEW023111206$18.0K841,7140.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$12.6K453,8900.0%
Allakos Inc(ALLKGUSD)COM01671P100$12.3K128,6620.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$10.0K161,9490.0%
Neoleukin Therapeutics IncCOM64049K104$10.0K810,0730.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$7.7K401,6090.0%
Achillion Pharmaceuticals in(ACHNEUR)COM00448Q201$3.8K624,9560.0%
Intersect ENT IncCOM46071F103$2.0K80,2380.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$1.8K165,3180.0%
Proteon Therapeutics IncCOM74371L109$140341,7430.0%